Manning & Napier Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-440,566
| Closed | -$47.7M | – | 286 |
|
|
2021
Q1 | $47.7M | Buy |
440,566
+8,491
| +2% | +$919K | 0.4% | 72 |
|
|
2020
Q4 | $46.3M | Sell |
432,075
-27,966
| -6% | -$3M | 0.43% | 69 |
|
|
2020
Q3 | $40.3M | Buy |
460,041
+6,262
| +1% | +$548K | 0.41% | 71 |
|
|
2020
Q2 | $44.6M | Sell |
453,779
-3,372
| -0.7% | -$331K | 0.48% | 64 |
|
|
2020
Q1 | $34.8M | Sell |
457,151
-2,773
| -0.6% | -$211K | 0.41% | 64 |
|
|
2019
Q4 | $40.7M | Buy |
459,924
+38,385
| +9% | +$3.4M | 0.44% | 61 |
|
|
2019
Q3 | $31.9M | Buy |
421,539
+2,250
| +0.5% | +$170K | 0.36% | 71 |
|
|
2019
Q2 | $30.5M | Buy |
419,289
+39,969
| +11% | +$2.91M | 0.33% | 74 |
|
|
2019
Q1 | $30.6M | Buy |
379,320
+83,583
| +28% | +$6.74M | 0.33% | 68 |
|
|
2018
Q4 | $27.3M | Buy |
295,737
+9,118
| +3% | +$841K | 0.33% | 62 |
|
|
2018
Q3 | $27.1M | Buy |
286,619
+20,976
| +8% | +$1.98M | 0.27% | 79 |
|
|
2018
Q2 | $24.6M | Sell |
265,643
-10,003
| -4% | -$927K | 0.24% | 83 |
|
|
2018
Q1 | $26.1M | Buy |
275,646
+40,902
| +17% | +$3.87M | 0.26% | 78 |
|
|
2017
Q4 | $22.7M | Buy |
+234,744
| New | +$22.7M | 0.2% | 85 |
|